Search results for "Opioids"
Coadministration of antidepressants, certain opioids linked to adverse events in nursing home patients
Older nursing home patients who received both CYP2D6-metabolized opioids and CYP2D6-inhibiting antidepressants were at higher risk for worsening pain, pain-related hospitalization, pain-related ED visits, and opioid use disorder in a recent study.
https://immattersacp.org/weekly/archives/2024/07/23/1.htm
23 Jul 2024
Potential problematic prescribing in older women
Prescription of systemic estrogen therapy after menopause could be a red flag for use of other medications linked to dementia.
https://immattersacp.org/archives/2024/04/potential-problematic-prescribing-in-older-women.htm
1 Apr 2024
Low back pain patients with opioid use disorder more likely to get more opioids
One-quarter of Medicare beneficiaries seeking care for acute low back pain received opioid prescriptions, according to 2016 to 2019 data. Patients with opioid use disorder received higher opioid doses and were more likely to be coprescribed gabapentin.
https://immattersacp.org/weekly/archives/2024/06/11/4.htm
11 Jun 2024
New 'weighs' to treat obesity
Even as the data on weight loss drugs mount, physicians need to help patients navigate potentially prohibitive costs and a continuing need for lifestyle change.
https://immattersacp.org/archives/2024/03/new-weighs-to-treat-obesity.htm
1 Mar 2024
Opioid use declined in chronic pain patients with no increase in nonpharmacologic therapy
Surveys from 2020 showed that about 1 in 4 adults with recent chronic pain reported using pharmacologic therapies only, showing a need to increase nonpharmacologic therapy use, according to the study authors.
https://immattersacp.org/weekly/archives/2023/11/21/1.htm
21 Nov 2023
Routine opioid use disorder screening fails to significantly increase new diagnosis rates
This may be due to the sensitivity of the screening instrument, compounded by the stigma of opioid use disorder; addressing the latter may increase the instrument's sensitivity, the authors suggest.
https://immattersacp.org/weekly/archives/2023/10/17/2.htm
17 Oct 2023
New UTI treatment, AI sepsis risk calculator approved
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2024/06/fda.htm
1 Jun 2024
Drug screens early during treatment for OUD predict risk of return to opioid use
Patients whose urine drug screens in the three weeks after beginning treatment for opioid use disorder (OUD) were negative for opioids had a 13% risk of returning to opioid use compared with 85% for those with three weeks of opioid-positive or missing results.
https://immattersacp.org/weekly/archives/2023/10/10/2.htm
10 Oct 2023
Big barrier to buprenorphine removed
The U.S. government no longer requires an X waiver to treat patients with buprenorphine for opioid use disorder.
https://immattersacp.org/archives/2023/03/big-barrier-to-buprenorphine-removed.htm
1 Mar 2023
Telehealth visits may improve outcomes for opioid use disorder
A cross-sectional study of U.S. insurance claims found that buprenorphine initiation during a telehealth visit was associated with a 36% lower overdose rate than in person and that patients in the former group were more likely to refill their prescriptions.
https://immattersacp.org/weekly/archives/2023/09/12/1.htm
12 Sep 2023